GENERAL NOTICES/ERRATA
STATE AIR POLLUTION CONTROL BOARD
Proposed State Implementation Plan - Revision H12
Notice of action: The Department of Environmental Quality (DEQ) is announcing an opportunity for public comment on a proposed revision to the Commonwealth of Virginia State Implementation Plan (SIP). The SIP is a plan developed by the Commonwealth in order to fulfill its responsibilities under the federal Clean Air Act to attain and maintain the ambient air quality standards promulgated by the U.S. Environmental Protection Agency (EPA) under the Act. The Commonwealth intends to submit the regulation to EPA as a revision to the SIP in accordance with the requirements of § 110(a) of the federal Clean Air Act.
Regulations affected: The regulation of the board affected by this action is Permits for Stationary Sources of Pollutants Subject to Regulation, 9VAC5-85 (Revision H12) regarding greenhouse gas plantwide applicability limits.
Purpose of notice: DEQ is seeking comments on the issue of whether the regulation amendments should be submitted as revisions to the plan.
Public comment period: April 7, 2014, to May 7, 2014.
Public hearing: A public hearing may be conducted if a request is made in writing to the contact listed below. In order to be considered, the request must include the full name, address, and telephone number of the person requesting the hearing and be received by DEQ by the last day of the comment period. Notice of the date, time, and location of any requested public hearing will be announced in a separate notice, and another 30-day comment period will be conducted.
Public comment stage: Because the regulation amendments have been adopted by the board in accordance with the Administrative Process Act and have subsequently become effective, DEQ is accepting comment only on the issue cited above under "purpose of notice" and not on the content of the regulation amendments.
Description of proposal: On July 12, 2012, EPA promulgated final amendments to its regulations for permitting of greenhouse gases (GHGs) (see 77 FR 41051). The purpose of these amendments is to provide for better implementation of the federal program for establishing plantwide applicability limits (PALs) for GHG emissions. A PAL establishes a site-specific plantwide emission level for a pollutant that allows the source to make changes at the facility without triggering the requirements of the prevention of significant deterioration (PSD) program. Such PALs are already available under PSD for non-GHG pollutants and for GHGs on a mass basis, and EPA has revised the PAL regulations to allow for GHG PALs to be established on a carbon dioxide equivalent (CO2e) emissions basis as well. EPA also revised its regulations to allow a GHG-only source to submit an application for a CO2e-based GHG PAL while also maintaining its minor source status. Because these actions could streamline PSD permitting, it would be beneficial to implement them in Virginia.
Federal information: This notice is being given to satisfy the public participation requirements of federal regulations (40 CFR 51.102). The proposal will be submitted as a revision to the Commonwealth of Virginia SIP under § 110(a) of the federal Clean Air Act in accordance with 40 CFR 51.104. It is planned to submit all provisions of the proposal as a revision to the Commonwealth of Virginia SIP.
How to comment: DEQ accepts written comments by email, fax, and postal mail. In order to be considered, comments must include the full name, address, and telephone number of the person commenting and be received by DEQ by the last day of the comment period. All materials received are part of the public record.
To review proposal: The proposal and any supporting documents are available on the DEQ Air Public Notices for Plans website at http://www.deq.state.va.us/Programs/Air/PublicNotices/airplansandprograms.aspx. The documents may also be obtained by contacting the DEQ representative named below. The public may review the documents between 8:30 a.m. and 4:30 p.m. of each business day until the close of the public comment period at the following DEQ locations:
1) Main Street Office, 8th Floor, 629 East Main Street, Richmond, VA, telephone (804) 698-4070;
2) Southwest Regional Office, 355 Deadmore Street, Abingdon, VA, telephone (276) 676-4800;
3) Blue Ridge Regional Office, Roanoke Location, 3019 Peters Creek Road, Roanoke, VA, telephone (540) 562-6700;
4) Blue Ridge Regional Office, Lynchburg Location, 7705 Timberlake Road, Lynchburg, VA, telephone (434) 582-5120;
5) Valley Regional Office, 4411 Early Road, Harrisonburg, VA, telephone (540) 574-7800;
6) Piedmont Regional Office, 4949-A Cox Road, Glen Allen, VA, telephone (804) 527-5020;
7) Northern Regional Office, 13901 Crown Court, Woodbridge, VA, telephone (703) 583-3800; and
8) Tidewater Regional Office, 5636 Southern Boulevard, Virginia Beach, VA, telephone (757) 518-2000.
Contact Information: Karen G. Sabasteanski, Department of Environmental Quality, 629 East Main Street, P.O. Box 1105, Richmond, VA 23218, telephone (804) 698-4426, FAX (804) 698-4510, or email karen.sabasteanski@deq.virginia.gov.
STATE CORPORATION COMMISSION
Bureau of Insurance
March 7, 2014
Administrative Letter 2014-03
TO: All Insurers Licensed to Write Accident and Sickness Insurance in Virginia, and All Health Services Plans and Health Maintenance Organizations Licensed in Virginia
RE: 14VAC5-190-10 et seq.: Rules Governing the Reporting of Cost and Utilization Data Relating to Mandated Benefits and Mandated Providers - 2013 Reporting Period
The purpose of this Administrative Letter is to assist carriers in the preparation of the Annual Report of Cost and Utilization Data relating to Mandated Benefits and Providers required pursuant to 14VAC5-190-10 et seq. and § 38.2-3419.1 of the Code of Virginia, and to remind all affected carriers of the reporting requirements applicable to mandated benefits and providers for the 2013 reporting year.
The Virginia total annual written premiums for all accident and sickness policies or contracts referenced in the regulation is the amount reported to the Commission on the company's Annual Statement for the year ending December 31, 2013. This is the amount used to determine if a report is required. If the total annual written premium reported to Virginia for all accident and sickness lines is less than $500,000 or the company is licensed to issue only credit accident and sickness insurance, the company is EXEMPT from filing any information and a report is not required.
A company may be required to file a COMPLETE report or an ABBREVIATED report if the total annual written premium reported to Virginia for all accident and sickness lines is at least $500,000 (excluding credit only accident and sickness). Carriers should refer to 14VAC5-190-40 for an explanation of the circumstances under which a COMPLETE or an ABBREVIATED report must be filed.
Each affected carrier must submit a completed Form MB-1 to furnish the required information. It is not acceptable to submit more than one Form MB-1 for a single carrier or to consolidate information from different carriers on one form.
The completed Form MB-1 (cover sheet and sections) is due on or before May 1, 2014, and may be submitted electronically. The due date may not be extended for any reason, including the inability to file the reports electronically. The instructions, representative CPT and ICD-9-CM codes, and forms for the 2013 reporting period are available on the Bureau of Insurance's website at http://www.scc.virginia.gov/boi/co/health/mandben.aspx.
The instructions explain the type of information necessary to complete Form MB-1. All sources of information, including 14VAC5-190-10 et seq., §§ 38.2-3408 through 38.2-3418.17, as applicable, § 38.2-4221, and CPT and ICD-9-CM codes, should be consulted in the preparation of this report. Please note that the CPT and ICD-9-CM codes are not intended to exhaust all medical codes that may be used in collecting data for Form MB-1, but are representative of some of the more common codes associated with the mandated benefits.
Carriers are reminded that failure to submit a substantially complete and accurate report pursuant to the provisions of 14VAC5-190-10 et seq., by May 1, 2014, may be considered a violation subject to a penalty as set forth in § 38.2-218 of the Code of Virginia. Lack of notice, lack of information, lack of means of producing the required data, or other such reasons will not be accepted for not submitting a complete and accurate report in a timely manner.
Correspondence regarding reporting requirements should be directed to: Mary Ann Mason, Principal Insurance Market Examiner, Forms and Rates Section, Bureau of Insurance, Life and Health Division, P.O. Box 1157, Richmond, VA 23218, telephone (804) 371-9348, FAX (804) 371-9944, email maryann.mason@scc.virginia.gov.
System related questions or problems should be directed to: Andrew Iverson, Insurance Analyst, Bureau of Insurance, Automated Systems, P.O. Box 1157, Richmond, VA 23218, telephone (804) 371-9851, FAX (804) 371-9516, email andrew.iverson@scc.virginia.gov.
/s/ Jacqueline K. Cunningham
Commissioner of Insurance
DEPARTMENT OF ENVIRONMENTAL QUALITY
Total Maximum Daily Load for North Creek Watershed
Purpose of notice: The Virginia Department of Environmental Quality (DEQ) announces the release of an updated draft total maximum daily load (TMDL) report. Final public meeting was held on October 4, 2011, and since that meeting, changes were made to the draft TMDL report. The TMDL report was developed to document a study to restore water quality in the North Creek watershed. The draft TMDL report is posted on the DEQ website at http://www.deq.virginia.gov/Programs/Water/WaterQualityInformationTMDLs/TMDL/TMDLDevelopment/DraftTMDLReports.aspx.
Description of study: Virginia agencies are working to identify sources of biological impairment (general standard) in the North Creek watershed. The general standard indicates the water quality does not support a natural aquatic invertebrate community.
The following is the "impaired" stream, the length of the impaired segment, location and the reason for the impairment: North Creek, 6.5 miles, to include the entire headwaters and extends to the mouth of the South River, Fluvanna County, general standard (aquatic invertebrate community).
DEQ, in cooperation with the Virginia Department of Conservation and Recreation and other state and local agencies developed a TMDL study for the impaired waters. A TMDL is the total amount of a pollutant a water body can contain and still meet water quality standards. To restore water quality, contamination levels have to be reduced to the TMDL amount.
How to comment: DEQ accepts written comments by email, fax, or postal mail. Written comments should include the name, address, and telephone number of the person commenting and be received by May 7, 2014. DEQ also accepts written and oral comments at the public meeting announced in this notice.
For additional information or to submit comments, contact Paula Nash, Virginia Department of Environmental Quality, Blue Ridge Regional Office, 7705 Timberlake Road, Lynchburg, VA 24502, telephone (540) 582-6216, or email paula.nash@deq.virginia.gov.
Additional information is also available on the DEQ website at http://www.deq.virginia.gov/Programs/Water/WaterQualityInformationTMDLs/TMDL/TMDLDevelopment.aspx.
Total Maximum Daily Load Studies in Red Bank Creek and a Portion of Machipongo River, Northampton and Accomack Counties
The Virginia Department of Environmental Quality (DEQ) will provide a public comment period for water quality studies for Red Bank Creek and a portion of Machipongo River, located in Northampton and Accomack Counties. Since the final public meeting, changes to the total maximum daily load (TMDL) reduction scenario tables have been made. Before EPA can approve the TMDL report, the revisions are being made available for public comment and review.
The report and revisions may be accessed on the DEQ website at http://www.deq.virginia.gov/Programs/Water/WaterQualityInformationTMDLs.aspx.
Red Bank Creek (Enterococci, E.coli, Fecal coliform) and Machipongo River (Fecal coliform, Enterococci), were identified in Virginia's 2010 Water Quality Assessment and Integrated Report as impaired due to violations of the State's water quality standards for recreation bacteria and shellfish consumption bacteria and do not support the designated uses. The Red Bank Creek watershed includes both riverine and tidal portions of the creek. The Machipongo River watershed only includes the estuarine area of the stream covered from the end of tidal waters downstream to 0.5 mile south of Route 182.
Section 303(d) of the Clean Water Act and § 62.1-44.19:7 C of the Code of Virginia require DEQ to develop TMDLs for pollutants responsible for each impaired water contained in Virginia's § 303(d) TMDL Priority List and Report and subsequent water quality assessment reports.
During the study, DEQ developed a TMDL for the impaired waters. A TMDL is the total amount of a pollutant a water body can contain and still meet water quality standards. To restore water quality, pollutant levels have to be reduced to the TMDL amount. The Virginia Department of Environmental Quality, Virginia Department of Health, and other local agencies are working to identify the sources of pollution in the watersheds of these streams.
The public comment period will extend from April 7, 2014, through May 6, 2014.
For additional information or to submit comments, contact Jennifer Howell, Virginia Department of Environmental Quality, Tidewater Regional Office, 5636 Southern Boulevard, Virginia Beach, VA 23462, telephone (757) 518-2111, or email jennifer.howell@deq.virginia.gov.
Additional information is also available on the DEQ website at http://www.deq.virginia.gov/Programs/Water/WaterQualityInformationTMDLs.aspx.
DEPARTMENT OF FORENSIC SCIENCE
Approval of Field Tests for Detection of Drugs
In accordance with 6VAC40-30, the Regulations for the Approval of Field Tests for Detection of Drugs, and under the authority of the Code of Virginia, the following field tests for detection of drugs are approved field tests:
| O D V INCORPORATED 13386 INTERNATIONAL PARKWAY JACKSONVILLE, FLORIDA 32218-2383 |
| ODV NarcoPouch |
| Drug or Drug Type: | Manufacturer's Field Test: |
| Heroin | 902 – Marquis Reagent |
| Amphetamine | 902 – Marquis Reagent |
| Methamphetamine | 902 – Marquis Reagent |
| 3,4–Methylenedioxymethamphetamine (MDMA) | 902 – Marquis Reagent |
| Cocaine Hydrochloride | 904 or 904B – Cocaine HCl and Base Reagent |
| Cocaine Base | 904 or 904B – Cocaine HCl and Base Reagent |
| Barbiturates | 905 – Dille-Koppanyi Reagent |
| Lysergic Acid Diethylamide (LSD) | 907 – Ehrlich's (Modified) Reagent |
| Marijuana | 908 – Duquenois – Levine Reagent |
| Hashish Oil | 908 – Duquenois – Levine Reagent |
| Marijuana | 909 – K N Reagent |
| Hashish Oil | 909 – K N Reagent |
| Phencyclidine (PCP) | 914 – PCP Methaqualone Reagent |
| Heroin | 922 – Opiates Reagent |
| Methamphetamine | 923 – Methamphetamine/Ecstasy Reagent |
| 3,4–Methylenedioxymethamphetamine (MDMA) | 923 – Methamphetamine/Ecstasy Reagent |
| Heroin | 924 – Mecke's (Modified) Reagent |
| Diazepam | 925 – Valium/Ketamine Reagent |
| Ketamine | 925 – Valium/Ketamine Reagent |
| Ephedrine | 927 – Ephedrine Reagent |
| gamma – Hydroxybutyrate (GHB) | 928 – GHB Reagent |
| ODV NarcoTest |
| Drug or Drug Type: | Manufacturer's Field Test: |
| Heroin | 7602 – Marquis Reagent |
| Amphetamine | 7602 – Marquis Reagent |
| Methamphetamine | 7602 – Marquis Reagent |
| 3,4–Methylenedioxymethamphetamine (MDMA) | 7602 – Marquis Reagent |
| Barbiturates | 7605 – Dille-Koppanyi Reagent |
| Lysergic Acid Diethylamide (LSD) | 7607 – Ehrlich's (Modified) Reagent |
| Marijuana | 7608 – Duquenois Reagent |
| Hashish Oil | 7608 – Duquenois Reagent |
| Marijuana | 7609 – K N Reagent |
| Hashish Oil | 7609 – K N Reagent |
| Cocaine Hydrochloride | 7613 – Scott (Modified) Reagent |
| Cocaine Base | 7613 – Scott (Modified) Reagent |
| Phencyclidine (PCP) | 7614 – PCP Methaqualone Reagent |
| Heroin | 7622 – Opiates Reagent |
| Methamphetamine | 7623 – Methamphetamine/Ecstasy Reagent |
| 3,4–Methylenedioxymethamphetamine (MDMA) | 7623 – Methamphetamine/Ecstasy Reagent |
| Heroin | 7624 – Mecke's Reagent |
| Diazepam | 7625 – Valium/Ketamine Reagent |
| Ketamine | 7625 – Valium/Ketamine Reagent |
| Ephedrine | 7627 – Chen's Reagent - Ephedrine |
| gamma – Hydroxybutyrate (GHB) | 7628 – GHB Reagent |
| SIRCHIE FINGERPRINT LABORATORIES 100 HUNTER PLACE YOUNGSVILLE, NORTH CAROLINA 27596 |
| NARK |
| Drug or Drug Type: | Manufacturer's Field Test: |
| Narcotic Alkaloids | 1 – Mayer's Reagent |
| Heroin | 1 – Mayer's Reagent |
| Morphine | 1 – Mayer's Reagent |
| Amphetamine | 1 – Mayer's Reagent |
| Methamphetamine | 1 – Mayer's Reagent |
| Opium Alkaloids | 2 – Marquis Reagent |
| Heroin | 2 – Marquis Reagent |
| Morphine | 2 – Marquis Reagent |
| Amphetamine | 2 – Marquis Reagent |
| Methamphetamine | 2 – Marquis Reagent |
| 3,4–Methylenedioxymethamphetamine (MDMA) | 2 – Marquis Reagent |
| Meperidine (Demerol) (Pethidine) | 2 – Marquis Reagent |
| Heroin | 3 – Nitric Acid |
| Morphine | 3 – Nitric Acid |
| Cocaine Hydrochloride | 4 – Cobalt Thiocyanate Reagent |
| Cocaine Base | 4 – Cobalt Thiocyanate Reagent |
| Procaine | 4 – Cobalt Thiocyanate Reagent |
| Tetracaine | 4 – Cobalt Thiocyanate Reagent |
| Barbiturates | 5 – Dille-Koppanyi Reagent |
| Heroin | 6 – Mandelin Reagent |
| Morphine | 6 – Mandelin Reagent |
| Amphetamine | 6 – Mandelin Reagent |
| Methamphetamine | 6 – Mandelin Reagent |
| Lysergic Acid Diethylamide (LSD) | 7 – Ehrlich's Reagent |
| Marijuana | 8 – Duquenois Reagent |
| Hashish | 8 – Duquenois Reagent |
| Hashish Oil | 8 – Duquenois Reagent |
| Tetrahydrocannabinol (THC) | 8 – Duquenois Reagent |
| Marijuana | 9 – NDB (Fast Blue B Salt) Reagent |
| Hashish | 9 – NDB (Fast Blue B Salt) Reagent |
| Hashish Oil | 9 – NDB (Fast Blue B Salt) Reagent |
| Tetrahydrocannabinol (THC) | 9 – NDB (Fast Blue B Salt) Reagent |
| Cocaine Base | 13 – Cobalt Thiocyanate/Crack Test |
| NARK II |
| Drug or Drug Type: | Manufacturer's Field Test: | |
| Narcotic Alkaloids | 01 – Marquis Reagent | |
| Heroin | 01 – Marquis Reagent | |
| Morphine | 01 – Marquis Reagent | |
| Amphetamine | 01 – Marquis Reagent | |
| Methamphetamine | 01 – Marquis Reagent | |
| 3,4–Methylenedioxymethamphetamine (MDMA) | 01 – Marquis Reagent | |
| Morphine | 02 – Nitric Acid | |
| Heroin | 02 – Nitric Acid | |
| Barbiturates | 03 – Dille-Koppanyi Reagent | |
| Lysergic Acid Diethylamide (LSD) | 04 – Ehrlich's Reagent | |
| Marijuana | 05 – Duquenois – Levine Reagent | |
| Hashish | 05 – Duquenois – Levine Reagent | |
| Hashish Oil | 05 – Duquenois – Levine Reagent | |
| Tetrahydrocannabinol (THC) | 05 – Duquenois – Levine Reagent | |
| Cocaine Hydrochloride | 07 – Scott's (Modified) Reagent | |
| Cocaine Base | 07 – Scott's (Modified) Reagent | |
| Phencyclidine (PCP) | 09 – Phencyclidine Reagent | |
| Opiates | 10 – Opiates Reagent | |
| Heroin | 10 – Opiates Reagent | |
| Morphine | 10 – Opiates Reagent | |
| Buprenorphine | 10 – Special Opiates Reagent | |
| Heroin | 11 – Mecke's Reagent | |
| 3,4–Methylenedioxymethamphetamine (MDMA) | 11 – Mecke's Reagent | |
| Pentazocine | 12 – Talwin/ Pentazocine Reagent | |
| Ephedrine | 13 – Ephedrine Reagent | |
| Diazepam | 14 – Valium Reagent | |
| Methamphetamine | 15 – Methamphetamine (Secondary Amines Reagent) | |
| Narcotic Alkaloids | 19 – Mayer's Reagent | |
| Heroin | 19 – Mayer's Reagent | |
| Morphine | 19 – Mayer's Reagent | |
| Amphetamine | 19 – Mayer's Reagent | |
| Methamphetamine | 19 – Mayer's Reagent | |
| 3,4-Methylenedioxypyrovalerone (MDPV) | 24 – MDPV (Bath Salts) Reagent | |
| Beta-keto-N-methyl-3,4-benzodioxyolybutanamine (other name: butylone) | 24 – MDPV Synthetic Cathinones Reagent | |
| 3,4-methylenedioxyethcathinone (other name: ethylone) | 24 – MDPV Synthetic Cathinones Reagent | |
| 3,4-methylenedioxymethcathinone (other name: methylone) | 24 – MDPV Synthetic Cathinones Reagent | |
| Naphthylpyrovalerone (other name: naphyrone) | 24 – MDPV Synthetic Cathinones Reagent | |
| Beta-keto-methylbenzodioxolylpentanamine (other name: pentylone) | 24 – MDPV Synthetic Cathinones Reagent | |
| 4-Methylmethcathinone (Mephedrone) | 25 – Mephedrone (Bath Salts) Reagent | |
| Alpha-pyrrolidinovalerophenone (other name: alpha-PVP) | 26 – A-PVP (Synthetic Stimulant) Reagent | |
| 4-Bromo-2,5-dimethoxyphenethylamine (other name: 2C-B) | 29 - 2C Reagent | |
| 2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (other name: 2C-C) | 29 – 2C Reagent | |
| 4-Ethyl-2,5-dimethoxyphenethylamine (other name: 2C-E) | 29 – 2C Reagent | |
| 4-Iodo-2,5-dimethoxyphenethylamine (other name: 2C-I) | 29 – 2C Reagent | |
| 2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine (other name: | 29 – 2C Reagent | |
| 2C-N) | | |
| 2,5-dimethoxy-4-(n)-propylthiophenethylamine (other name: 2C-T-7) | 29 – 2C Reagent | |
| Psilocybin | 30 – Psilocybin/Psilocin Reagent | |
| Methamphetamine | 31 – Liebermann Reagent | |
| Morphine | 31 – Liebermann Reagent | |
| ARMOR HOLDINGS, INCORPORATED 13386 INTERNATIONAL PARKWAY JACKSONVILLE, FLORIDA 32218-2383 |
| NIK |
| Drug or Drug Type: | Manufacturer's Field Test: |
| Heroin | Test A 6071 – Marquis Reagent |
| Amphetamine | Test A 6071 – Marquis Reagent |
| Methamphetamine | Test A 6071 – Marquis Reagent |
| 3,4–Methylenedioxymethamphetamine (MDMA) | Test A 6071 – Marquis Reagent |
| Morphine | Test B 6072 – Nitric Acid Reagent |
| Barbiturates | Test C 6073 – Dille-Koppanyi Reagent |
| Lysergic Acid Diethylamide (LSD) | Test D 6074 – LSD Reagent System |
| Marijuana | Test E 6075 – Duquenois – Levine Reagent |
| Hashish Oil | Test E 6075 – Duquenois – Levine Reagent |
| Tetrahydrocannabinol | Test E 6075 – Duquenois – Levine Reagent |
| Cocaine Hydrochloride | Test G 6077 – Scott (Modified) Reagent |
| Cocaine Base | Test G 6077 – Scott (Modified) Reagent |
| Cocaine Hydrochloride | 6500 or 6501 – Cocaine ID Swab |
| Cocaine Base | 6500 or 6501 – Cocaine ID Swab |
| Phencyclidine (PCP) | Test J 6079 – PCP Reagent System |
| Heroin | Test K 6080 – Opiates Reagent |
| Heroin | Test L 6081 – Brown Heroin Reagent System |
| gamma – Hydroxybutyrate (GHB) | Test O 6090 – GHB Reagent |
| Ephedrine | Test Q 6085 – Ephedrine Reagent |
| Pseudoephedrine | Test Q 6085 – Ephedrine Reagent |
| Diazepam | Test R 6085 – Valium Reagent |
| Methamphetamine | Test U 6087 – Methamphetamine Reagent |
| 3,4–Methylenedioxymethamphetamine (MDMA) | Test U 6087 – Methamphetamine Reagent |
| Methadone | Test W 6088 – Mandelin Reagent System |
| MISTRAL SECURITY INCORPORATED 7910 WOODMONT AVENUE SUITE 820 BETHESDA, MARYLAND 20814 |
| Drug or Drug Type: | Manufacturer's Field Test: |
| Heroin | Detect 4 Drugs Aerosol |
| Amphetamine | Detect 4 Drugs Aerosol |
| Methamphetamine | Detect 4 Drugs Aerosol |
| Marijuana | Detect 4 Drugs Aerosol |
| Hashish Oil | Detect 4 Drugs Aerosol |
| Methamphetamine | Meth 1 and 2 Aerosol |
| Heroin | Herosol Aerosol |
| Marijuana | Cannabispray 1 and 2 Aerosol |
| Hashish Oil | Cannabispray 1 and 2 Aerosol |
| Cocaine Hydrochloride | Coca-Test Aerosol |
| Cocaine Base | Coca-Test Aerosol |
| Marijuana | Pen Test – D4D |
| Phencyclidine | Pen Test – D4D |
| Amphetamine | Pen Test – D4D |
| Ketamine | Pen Test – D4D |
| Methamphetamine | Pen Test – D4D |
| Ephedrine | Pen Test – D4D |
| Heroin | Pen Test – D4D |
| Methadone | Pen Test – D4D |
| Buprenorphine | Pen Test – D4D |
| Opium | Pen Test – D4D |
| Phenobarbital | Pen Test – Barbitusol |
| Marijuana | Pen Test – Cannabis Test |
| Phencyclidine | Pen Test – Coca Test |
| Cocaine Hydrochloride | Pen Test – Coca Test |
| Cocaine base | Pen Test – Coca Test |
| Buprenorphine | Pen Test – C&H Test |
| Cocaine Hydrochloride | Pen Test – C&H Test |
| Cocaine base | Pen Test – C&H Test |
| Ephedrine | Pen Test – C&H Test |
| Ketamine | Pen Test – C&H Test |
| Heroin | Pen Test – C&H Test |
| Lysergic Acid Diethylamide (LSD) | Pen Test – C&H Test |
| Methadone | Pen Test – C&H Test |
| Methamphetamine | Pen Test – C&H Test |
| Heroin | Pen Test – Herosol |
| Methadone | Pen Test – Herosol |
| Lysergic Acid Diethylamide | Pen Test – LSD Test |
| Methamphetamine | Pen Test – Meth/X Test |
| 3,4-Methylenedioxymethamphetamine (MDMA) | Pen Test – Meth/X Test |
| Morphine | Pen Test – Opiatest |
| Opium | Pen Test – Opiatest |
| Diazepam | Pen Test – BZO |
| Ephedrine | Pen Test – Ephedrine |
| Pseudoephedrine | Pen Test – Ephedrine |
| Amphetamine | 101 PDT Marquis Reagent |
| Heroin | 101 PDT Marquis Reagent |
| 3,4-Methylenedioxymethamphetamine (MDMA) | 101 PDT Marquis Reagent |
| Phenobarbital | 107 PDT Dille-Koppanyi Reagent |
| Lysergic Acid Diethylamide | 110 PDT Modified Ehrlich Reagent |
| Marijuana | 119 PDT KN Reagent |
| Cocaine Hydrochloride | 122 PDT Modified Scott Reagent |
| Cocaine base | 122 PDT Modified Scott Reagent |
| Methaqualone | 143 PDT Methaqualone/PCP Reagent |
| Phencyclidine | 143 PDT Methaqualone/PCP Reagent |
| Heroin | 140 PDT Modified Mecke's Reagent |
| gamma-Hydroxybutyrate (GHB) | 149 PDT GHB Reagent |
| Ephedrine | 155 PDT Chen's Reagent |
| Diazepam | 158 PDT Valium/Rohypnol Reagent |
| Flunitrazepam | 158 PDT Valium/Rohypnol Reagent |
| Ketamine | 161 PDT Morris Reagent |
| Methamphetamine | 164 PDT Methamphetamine (MDMA/Ecstasy) Reagent |
| 3,4-Methylenedioxymethamphetamine (MDMA) | 164 PDT Methamphetamine (MDMA/Ecstasy) Reagent |
| Psilocybin | 167 PDT Psilocybin Reagent |
| 3,4-Methylenedioxypyrovalerone (MDPV) | 170 PDT Bath Salts: MDPV Reagent |
| 4-methylmethcathinone (Mephedrone) | 173 PDT Bath Salts: Mephedrone Reagent |
| Morphine | 137 PDT Opiates Reagent |
| JANT PHARMACAL CORPORATION 16255 VENTURA BLVD., #505 ENCINO, CA 91436 Formerly available through: MILLENNIUM SECURITY GROUP |
| Accutest IDenta |
| Drug or Drug Type: | Manufacturer's Field Test: |
| Marijuana | Marijuana/Hashish (Duquenois-Levine Reagent) |
| Hashish Oil | Marijuana/Hashish (Duquenois-Levine Reagent) |
| Heroin | Heroin Step 1 and Step 2 |
| Cocaine Hydrochloride | Cocaine/Crack Step 1 and Step 2 |
| Cocaine Base | Cocaine/Crack Step 1 and Step 2 |
| 3,4–Methylenedioxymethamphetamine (MDMA) | MDMA Step 1 and Step 2 |
| Methamphetamine | Methamphetamine Step 1 and Step 2 |
| COZART PLC 92 MILTON PARK ABINGDON, OXFORDSHIRE ENGLAND OX14 4RY |
| Drug or Drug Type: | Manufacturer's Field Test: |
| Cocaine | Cocaine Solid Field Test |
| LYNN PEAVEY COMPANY 10749 WEST 84TH TERRACE LEXEXA, KANSAS 66214 |
| QuickCheck |
| Drug or Drug Type: | Manufacturer's Field Test: |
| Marijuana | Marijuana – 10120 |
| Marijuana | Marijuana – 10121 |
| Hashish Oil | Marijuana – 10120 |
| Hashish Oil | Marijuana – 10121 |
| Heroin | Marquis – 10123 |
| Heroin | Heroin - 10125 |
| Cocaine Hydrochloride | Cocaine – 10124 |
| Cocaine Base | Cocaine – 10124 |
| Methamphetamine | Meth/Ecstasy – 10122 |
| Methamphetamine | Marquis – 10123 |
| MDMA | Meth/Ecstasy – 10122 |
| MDMA | Marquis - 10123 |
| M.M.C. INTERNATIONAL B.V. FRANKENTHALERSTRAAT 16-18 4816 KA BREDA THE NETHERLANDS | |
| Drug or Drug Type: | Manufacturer's Field Test: | |
| Heroin | Opiates/Amphetamine Test (Ampoule) | |
| Morphine | Opiates/Amphetamine Test (Ampoule) | |
| Amphetamine | Opiates/Amphetamine Test (Ampoule) | |
| Methamphetamine | Opiates/Amphetamine Test (Ampoule) | |
| Codeine | Opiates/Amphetamine Test (Ampoule) | |
| Marijuana | Cannabis Test (Ampoule) | |
| Hashish Oil | Cannabis Test (Ampoule) | |
| Cocaine Hydrochloride | Cocaine/Crack Test (Ampoule) | |
| Cocaine base | Cocaine/Crack Test (Ampoule) | |
| Heroin | Heroin Test (Ampoule) | |
| Ketamine | Ketamine Test (Ampoule) | |
| Methadone | Methadone Test (Ampoule) | |
| Methamphetamine | Crystal Meth/XTC Test (Ampoule) | |
| 3,4-Methylenedioxymethamphetamine (MDMA) | Crystal Meth/XTC Test (Ampoule) | |
| Morphine | M&H Test (Ampoule) | |
| Heroin | M&H Test (Ampoule) | |
| Ephedrine | Ephedrine HCL Test (Ampoule) | |
| Pseudoephedrine | Ephedrine HCL Test (Ampoule) | |
| Pentazocine | Pentazocine Test (Ampoule) | |
| Buprenorphine | Buprenorphine HCL Test (Ampoule) | |
| Gamma butyrolactone (GBL) | GBL Test (Ampoule) | |
| Gamma hydroxybutyric acid (GHB) | GHB Test (Ampoule) | |
| Oxycodone | Oxycodone Test (Ampoule) | |
| Oxymetholone | Steroids Test B (Ampoule) | |
| Testosterone | Steroids Test B (Ampoule) | |
| Methandrostenolone | Steroids Test B (Ampoule) | |
| Phenylacetone | PMK/BMK(BMK) Test (Ampoule) | |
| Lysergic Acid Diethylamide (LSD) | LSD Test (Ampoule) | |
| Phencyclidine (PCP) | PCP Test (Ampoule) | |
| Methaqualone | Methaqualone Test (Ampoule) | |
| Amobarbital | Barbiturates Test (Ampoule) | |
| Pentobarbital | Barbiturates Test (Ampoule) | |
| Phenobarbital | Barbiturates Test (Ampoule) | |
| Secobarbital | Barbiturates Test (Ampoule) | |
| Propoxyphene | Propoxyphene Test (Ampoule) | |
| Diazepam | V&R Test (Ampoule) | |
| Cocaine Hydrochloride | Cocaine/Crack Test (Spray) |
| Cocaine base | Cocaine/Crack Test (Spray) |
| Cocaine Hydrochloride | Cocaine Trace Wipes |
| Cocaine base | Cocaine Trace Wipes |
| Morphine | Opiate Cassette |
| Heroin | Opiate Cassette |
| 3,4-Methylenedioxymethamphetamine (MDMA) | MDMA/Ecstasy Cassette |
| Methamphetamine | Methamphetamine Cassette |
| Amphetamine | Amphetamine Cassette |
| REDXDEFENSE 7642 STANDISH PLACE ROCKVILLE, MD 20855 |
| XCAT |
| Drug or Drug Type: | Manufacturer's Field Test: |
| Cocaine Hydrochloride | COC-210 Card |
| Cocaine base | COC-210 Card |
| Phencyclidine | COC-210 Card |
| Heroin | HER-110 Card |
| Amphetamine | AMP-500 Card |
| Methamphetamine | AMP-500 Card |
| 3,4-Methylenedioxymethamphetamine (MDMA) | AMP-500 Card |
| Butylone | AMP-500 Card |
| Methedrone | AMP-500 Card |
| Methylone | AMP-500 Card |
| Mephedrone | AMP-500 Card |
| N-Benzylpiperazine (N-BZP) | AMP-500 Card |
| Mescaline | AMP-500 Card |
| 2C-I | AMP-500 Card |
STATE BOARD OF HEALTH
Notice of Periodic and Small Business Impact Review
Pursuant to Executive Order 14 (2010) and §§ 2.2-4007.1 and 2.2-4017 of the Code of Virginia, the State Board of Health is conducting a periodic review and small business impact review of 12VAC5-110, Regulations for the Immunization of School Children. The review of this regulation will be guided by the principles in Executive Order 14 (2010).
The purpose of this review is to determine whether this regulation should be repealed, amended, or retained in its current form. Public comment is sought on the review of any issue relating to this regulation, including whether the regulation (i) is necessary for the protection of public health, safety, and welfare or for the economical performance of important governmental functions; (ii) minimizes the economic impact on small businesses in a manner consistent with the stated objectives of applicable law; and (iii) is clearly written and easily understandable.
The comment period begins April 7, 2014, and ends April 28, 2014.
Comments may be submitted online to the Virginia Regulatory Town Hall at http://www.townhall.virginia.gov/L/Forums.cfm. Comments may also be sent to Laurie Forlano, Acting Director Office of Epidemiology, 109 Governor Street, Richmond, VA 23219, telephone (804) 864-8207, email laurie.forlano@vdh.virginia.gov.
Comments must include the commenter's name and address (physical or email) information in order to receive a response to the comment from the agency. Following the close of the
public comment period, a report of both reviews will be posted on the Town Hall and a report of the small business impact review will be published in the Virginia Register of Regulations.
Notice of Periodic and Small Business Impact Review
Pursuant to Executive Order 14 (2010) and §§ 2.2-4007.1 and 2.2-4017 of the Code of Virginia, the State Board of Health is conducting a periodic review and small business impact review of 12VAC5-508, Regulations Governing the Virginia Physician Loan Repayment Program. The review of this regulation will be guided by the principles in Executive Order 14 (2010).
The purpose of this review is to determine whether this regulation should be repealed, amended, or retained in its current form. Public comment is sought on the review of any issue relating to this regulation, including whether the regulation (i) is necessary for the protection of public health, safety, and welfare or for the economical performance of important governmental functions; (ii) minimizes the economic impact on small businesses in a manner consistent with the stated objectives of applicable law; and (iii) is clearly written and easily understandable.
The comment period begins April 7, 2014, and ends April 28, 2014.
Comments may be submitted online to the Virginia Regulatory Town Hall at http://www.townhall.virginia.gov/L/Forums.cfm. Comments may also be sent to Adrienne McFadden, Director of the Office of Minority Health and Health Equity, 109 Governor Street, Richmond, VA 23219, telephone (804) 864-7425, email adrienne.mcfadden@vdh.virginia.gov.
Comments must include the commenter's name and address (physical or email) information in order to receive a response to the comment from the agency. Following the close of the public comment period, a report of both reviews will be posted on the Town Hall and a report of the small business impact review will be published in the Virginia Register of Regulations.
STATE LOTTERY DEPARTMENT
Director's Orders
The following Director's Orders of the State Lottery Department were filed with the Virginia Registrar of Regulations on March 7, 2014. The orders may be viewed at the State Lottery Department, 900 East Main Street, Richmond, VA, or at the office of the Registrar of Regulations, 201 North 9th Street, 2nd Floor, Richmond, VA.
Director's Order Number Two (14)
"Mega Power Grocery Sweepstakes Promotion" Virginia Lottery Final Rules for Game Operation (effective March 1, 2014)
Director's Order Number Twenty-Two (14)
Virginia's Computer-Generated Game Lottery Powerball® Final Rules for Game Operation (effective with drawings beginning January 22, 2014, as set forth in the Multi-State "Powerball®" Official Game Rules, revised accordingly, and shall remain in full force and effect unless amended or rescinded by further Director's Order)
Director's Order Number Twenty-Four (14)
Virginia's Instant Game Lottery 1423 "Double Match" Final Rules for Game Operation (effective January 30, 2014)
Director's Order Number Twenty-Six (14)
Virginia Lottery's "2 Ways 2 Win" Second Chance Sweepstakes Final Rules for Game Operation (effective February 25, 2014)
Director's Order Number Twenty-Seven (14)
"Fas Mart/Virginia Lottery Bankroll Doubler Promotion" Virginia Lottery Retailer Incentive Program Requirements (effective on March 1, 2014, and shall remain in full force and effect until ninety (90) days after the conclusion of the Incentive Program, unless otherwise extended by the Director)
Director's Order Number Twenty-Eight (14)
Virginia's Computer-Generated Game "Win For Life" Final Rules for Game Operation (effective with tickets purchased for the February 26, 2014, drawing or later and shall remain in full force and effect unless amended or rescinded by further Director's Order. Upon the effective date, these rules shall supersede and replace any and all prior Virginia Lottery "Win For Life" game rules)
Director's Order Number Twenty-Nine (14)
Virginia's Instant Game Lottery 1456 "I Heart Bacon" Final Rules for Game Operation (effective January 27, 2014)
Director's Order Number Thirty-One (14)
Virginia's Instant Game Lottery 1454 "Bankroll Doubler" Final Rules for Game Operation (effective February 20, 2014)
Director's Order Number Thirty-Two (14)
Virginia's Instant Game Lottery 1460 "Fast Cash" Final Rules for Game Operation (effective January 30, 2014)
Director's Order Number Thirty-Four (14)
Virginia's Instant Game Lottery 1326 "Triple The Money" Final Rules for Game Operation (effective February 20, 2014)
Director's Order Number Thirty-Five (14)
Virginia's Instant Game Lottery 1476 "High Voltage" Final Rules for Game Operation (effective February 20, 2014)
Director's Order Number Thirty-Six (14)
Virginia Lottery's "Epic Vegas Jackpot" Promotion Final Rules for Game Operation (effective on Tuesday, April 8, 2014, and shall remain in full force and effect unless amended or rescinded by further Director's Order)
Director's Order Number Forty (14)
Virginia Lottery's 3-4-5 Play Sweepstakes Final Rules for Operation (effective March 1, 2014)
Director's Order Number Forty-One (14)
"Epic Vegas Retailer Incentive Promotion" Virginia Lottery Retailer Incentive Program Requirements (effective on April 6, 2014, and shall remain in full force and effect until ninety (90) days after the conclusion of the Incentive Program, unless otherwise extended by the Director)
DEPARTMENT OF MEDICAL ASSISTANCE SERVICES
Notice of Intent to Amend the Virginia State Plan for Medical Assistance (pursuant to § 1902(a)(13) of the Act (USC 1396a(a)(13)))
The Virginia Department of Medical Assistance Services (DMAS) hereby affords the public notice of its intention to amend the Virginia State Plan for Medical Assistance to provide for changes to the Methods and Standards for Establishing Payment Rates; Other Types of Care (12VAC30-80). 12VAC30-80-30 is being amended to increase supplemental payments for physician practices affiliated with Type 1 hospitals. DMAS intends to revise the percent of Medicare, which represents the average commercial rate (ACR). The current ACR percent of Medicare is 181%. DMAS estimated that the percentage had increased to 189% effective January 1, 2013. DMAS estimates the percentage will increase to 200%. The final percentage will be subject to approval by the Centers for Medicare and Medicaid Services based on documentation furnished by the Type 1 hospitals and the methodology described in the State Plan. An ACR percent of Medicare of 200% will result in an annual increase in supplemental payments of approximately $1.7 million total funds.
This notice is intended to satisfy the requirements of 42 CFR 447.205 and of § 1902(a)(13) of the Social Security Act, 42 USC § 1396a(a)(13). A copy of this notice is available for public review from William Lessard, Provider Reimbursement Division, Department of Medical Assistance Services, 600 Broad Street, Suite 1300, Richmond, VA 23219, and this notice is available for public review on the Regulatory Town Hall (www.townhall.virginia.gov). Comments or inquiries may be submitted, in writing, within 30 days of this notice publication to Mr. Lessard and such comments are available for review at the same address.
Contact Information: William Lessard, Provider Reimbursement Division, Department of Medical Assistance Services, 600 East Broad Street, Suite 1300, Richmond, VA 23219, telephone (804) 225-4593, FAX (804) 786-1680, or email william.lessard@dmas.virginia.gov.
VIRGINIA WASTE MANAGEMENT BOARD
Notice of Periodic and Small Business Impact Review
Pursuant to Executive Order 14 (2010) and §§ 2.2-4007.1 and 2.2-4017 of the Code of Virginia, the Department of Environmental Quality on behalf of the Waste Management Board is conducting a periodic review and small business impact review of 9VAC20-120, Regulated Medical Waste Management Regulations. The review of this regulation will be guided by the principles in Executive Order 14 (2010).
The purpose of this review is to determine whether this regulation should be repealed, amended, or retained in its current form. Public comment is sought on the review of any issue relating to this regulation, including whether the regulation (i) is necessary for the protection of public health, safety, and welfare or for the economical performance of important governmental functions; (ii) minimizes the economic impact on small businesses in a manner consistent with the stated objectives of applicable law; and (iii) is clearly written and easily understandable.
The comment period begins April 7, 2014, and ends April 28, 2014.
Comments may be submitted online to the Virginia Regulatory Town Hall at http://www.townhall.virginia.gov/L/Forums.cfm. Comments may also be sent to Justin Williams, Office of Waste Permitting and Compliance Director, P.O. Box 1105, Richmond, VA 23218, telephone (804) 698-4185, FAX (804) 698-4234, or email justin.williams@deq.virginia.gov.
Comments must include the commenter's name and address (physical or email) information in order to receive a response to the comment from the agency. Following the close of the public comment period, a report of both reviews will be posted on the Town Hall and a report of the small business impact review will be published in the Virginia Register of Regulations.
STATE WATER CONTROL BOARD
Proposed Consent Special Order for Essex Concrete Corporation and Old Hall, LLC
An enforcement action has been proposed for Essex Concrete Corporation and Old Hall, LLC for alleged violations at Essex Concrete Corporation, Aylett site, King and Queen County. The State Water Control Board proposes to issue a consent special order to Essex Concrete Corporation and Old Hall, LLC to address noncompliance with State Water Control Law. A description of the proposed action is available at the Department of Environmental Quality office named below or online at www.deq.virginia.gov. Gina Pisoni will accept comments by email at gina.pisoni@deq.virginia.gov, FAX (804) 527-5106, or postal mail at Department of Environmental Quality, Piedmont Regional Office, 4949-A Cox Road, Glen Allen, VA 23060, from April 7, 2014, to May 9, 2014.
VIRGINIA CODE COMMISSION
Notice to State Agencies
Contact Information: Mailing Address: Virginia Code Commission, General Assembly Building, 201 North 9th Street, 2nd Floor, Richmond, VA 23219; Telephone: Voice (804) 786-3591; FAX (804) 692-0625; Email: varegs@dls.virginia.gov.
Meeting Notices: Section 2.2-3707 C of the Code of Virginia requires state agencies to post meeting notices on their websites and on the Commonwealth Calendar at http://www.virginia.gov/connect/commonwealth-calendar.
Cumulative Table of Virginia Administrative Code Sections Adopted, Amended, or Repealed: A table listing regulation sections that have been amended, added, or repealed in the Virginia Register of Regulations since the regulations were originally published or last supplemented in the print version of the Virginia Administrative Code is available at http://register.dls.virginia.gov/documents/cumultab.pdf.
Filing Material for Publication in the Virginia Register of Regulations: Agencies use the Regulation Information System (RIS) to file regulations and related items for publication in the Virginia Register of Regulations. The Registrar's office works closely with the Department of Planning and Budget (DPB) to coordinate the system with the Virginia Regulatory Town Hall. RIS and Town Hall complement and enhance one another by sharing pertinent regulatory information.
ERRATA
DEPARTMENT OF GENERAL SERVICES
Titles of Regulations: 1VAC30-40. Regulations for the Certification of Laboratories Analyzing Drinking Water (repealing 1VAC30-40-10 through 1VAC30-40-370).
1VAC30-41. Regulation for the Certification of Laboratories Analyzing Drinking Water (adding 1VAC30-41-10 through 1VAC30-41-500).
Publication: 30:14 VA.R. 1766-1778 March 10, 2014.
Correction to Final Regulation:
Page 1766, Summary, replace the summary in its entirety with the following:
Summary:
This regulatory action repeals 1VAC30-40 and replaces 1VAC30-40 with 1VAC30-41. 1VAC30-41 sets out the requirements to certify laboratories that analyze drinking water samples under the federal Safe Drinking Water Act. The amendments (i) update the drinking water laboratory certification regulation to incorporate by reference (a) the most recent federal regulations pertaining to drinking water test methods and related requirements (July 1, 2013) and (b) the most recent federal guidance used to certify drinking water laboratories--the Environmental Protection Agency's Manual for the Certification of Laboratories Analyzing Drinking Water, Fifth Edition (January 2005) and Supplement 1 to the Fifth Edition (June 2008); (ii) revise the fee provisions and require local, state, and federal public laboratories, as well as private or commercial laboratories, to pay fees for certification; and (iii) provide that drinking water laboratories may meet the requirements of 1VAC30-46, Accreditation for Commercial Environmental Laboratories, as an alternative to meeting the requirements of 1VAC30-41.
VA.R. Doc. No. R10-2245; Filed March 13, 2014, 3:17 p.m.